Tesamorelin 10mg Research Peptide
GHRH Analog · HIV-Associated Lipodystrophy Research · COA Verified
For research and laboratory use only. Not for human consumption. By purchasing, you confirm you are a qualified researcher.
Product Details
For Research Purposes Only. Not approved for human consumption.
Tesamorelin Research Peptide 10mg
Tesamorelin is a synthetic analog of Growth Hormone Releasing Hormone (GHRH) specifically engineered with a trans-3-hexenoic acid group to increase resistance to degradation and improve pharmacokinetics. It has been FDA-approved for reducing excess abdominal fat in HIV-associated lipodystrophy, making it one of the few research peptides with established clinical data in a specific metabolic condition. Tesamorelin serves as an important reference compound for researchers studying GHRH analogs in metabolic and body composition research.
Research Applications
GHRH analog pharmacokinetic research
Visceral adipose tissue and metabolic studies
HIV-associated lipodystrophy research models
GH axis and IGF-1 elevation studies
Body composition and lipodystrophy research
Quality Specifications
Purity: ≥98% (HPLC verified)
Compound: Tesamorelin
Molecular Weight: 5135.9 Da
Form: Lyophilized powder
Origin: Made in the USA
Testing: Third-party tested in a US laboratory
Storage: -20°C, protect from light
COA: Batch-specific, ISO-accredited laboratory
Frequently Asked Questions
Q: How does Tesamorelin differ from other GHRH analogs?A: Tesamorelin has a trans-3-hexenoic acid modification for enhanced stability. It is FDA-approved for HIV-associated lipodystrophy — one of the few peptides with clinical approval for a specific indication.
Q: What is lipodystrophy?A: Abnormal fat distribution — either loss (lipoatrophy) or accumulation (lipohypertrophy). Tesamorelin is approved specifically for HIV-associated abdominal lipohypertrophy.
Q: Why is Tesamorelin significant for research?A: Its FDA-approved status provides extensive clinical safety and efficacy data, making it a valuable reference compound when studying newer GHRH analogs.
Related Research: CJC-1295 No DAC | Sermorelin | Ipamorelin
For laboratory research use only. Not for human consumption. Not evaluated by the FDA.